TREATING CANCERS ASSOCIATED WITH OVEREXPRESSION OF CLASS I FAMILY OF RECEPTOR TYROSINE KINASES

摘要

Cancers associated with overexpression of class I family of receptor tyrosine kinases, e.g., with overexpression of HER-2/neu or overexpression of epidermal growth factor receptor, are treated with strongly binding PPARη ligands.